Gapping up
In reaction to strong earnings/guidance:
- N/A
M&A news:
- NXEO +14.9% (Univar to acquire Nexeo in cash and stock transaction valued at approx $2.0 bln or $11.65 per share)
- AVP +12.5% (Avon Products has attracted M&A interest from Natura Cosmeticos, according to WSJ)
- UNVR +1.2% (Univar to acquire Nexeo in cash and stock transaction valued at approx $2.0 bln or $11.65 per share)
Other news:
- VKTX +141.2% (announces 'positive' top-line results from a 12-week Phase 2 study of VK2809)
- TLRY +10.2% (US DEA has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego)
- UNP +4.7% (to launch Unified Plan 2020 Oct 1 -- will be rolled out in phases across the entire Union Pacific rail network)
- EEQ +4.3% (Enbridge confirms agreement to acquire all public equity of Enbridge Energy Partners (EEP) and Enbridge Energy Management)
- NFLX +1.1% (following last night's Emmy Awards) MA +0.7% (reaches agreement to settle monetary damages related to U.S. merchant litigation)
Analyst comments:
- IMGN +1.5% (initiated with Buy at Guggenheim)
- MRVL +1.4% (resumed with a Buy at Goldman)
- LB +1.3% (upgraded to Neutral from Underperform at BofA/Merrill)
- MD +1.2% (upgraded to Neutral from Underperform at BofA/Merrill)
- TRGP +1% (upgraded to Outperform from Market Perform at Wells Fargo)